tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market

Takeda Pharmaceutical Co (4502) Ratios

Compare
5 Followers

Takeda Pharmaceutical Co Ratios

JP:4502's free cash flow for Q4 2024 was ¥0.46. For the 2024 fiscal year, JP:4502's free cash flow was decreased by ¥ and operating cash flow was ¥-0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
0.97 1.11 0.97 1.21 1.53
Quick Ratio
0.57 0.58 0.57 0.81 1.10
Cash Ratio
0.21 0.20 0.21 0.40 0.54
Solvency Ratio
0.13 0.11 0.13 0.11 0.12
Operating Cash Flow Ratio
0.39 0.31 0.39 0.52 0.57
Short-Term Operating Cash Flow Coverage
2.88 1.95 2.88 5.51 45.63
Net Current Asset Value
¥ -5.21T¥ -5.28T¥ -5.21T¥ -4.90T¥ -5.02T
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.32 0.31 0.33 0.36
Debt-to-Equity Ratio
0.69 0.67 0.69 0.76 0.90
Debt-to-Capital Ratio
0.41 0.40 0.41 0.43 0.47
Long-Term Debt-to-Capital Ratio
0.39 0.38 0.39 0.42 0.47
Financial Leverage Ratio
2.20 2.08 2.20 2.32 2.50
Debt Service Coverage Ratio
2.21 1.85 2.21 3.00 3.67
Interest Coverage Ratio
2.89 1.39 2.89 2.77 2.05
Debt to Market Cap
0.65 0.74 0.65 0.79 0.74
Interest Debt Per Share
2.93K 3.19K 2.93K 2.89K 3.13K
Net Debt to EBITDA
3.25 5.01 3.25 2.95 3.73
Profitability Margins
Gross Profit Margin
69.11%66.43%69.11%68.99%68.91%
EBIT Margin
12.22%4.04%12.22%11.91%15.54%
EBITDA Margin
29.41%20.51%29.41%33.15%30.76%
Operating Profit Margin
12.18%5.02%12.18%12.91%15.93%
Pretax Profit Margin
9.31%1.24%9.31%8.48%11.45%
Net Profit Margin
7.87%3.38%7.87%6.45%11.76%
Continuous Operations Profit Margin
8.09%3.38%8.09%6.88%11.76%
Net Income Per EBT
84.52%272.90%84.52%76.03%102.67%
EBT Per EBIT
76.47%24.66%76.47%65.66%71.91%
Return on Assets (ROA)
2.27%0.95%2.27%1.75%2.91%
Return on Equity (ROE)
4.99%1.98%4.99%4.05%7.27%
Return on Capital Employed (ROCE)
4.27%1.67%4.27%4.18%4.57%
Return on Invested Capital (ROIC)
3.49%4.42%3.49%3.11%4.67%
Return on Tangible Assets
6.47%2.66%6.47%4.65%7.57%
Earnings Yield
4.70%2.21%4.70%4.21%6.04%
Efficiency Ratios
Receivables Turnover
5.91 6.11 5.91 4.93 3.93
Payables Turnover
4.05 4.47 4.05 3.74 4.28
Inventory Turnover
1.26 1.18 1.26 1.30 1.32
Fixed Asset Turnover
2.38 2.14 2.38 2.25 2.20
Asset Turnover
0.29 0.28 0.29 0.27 0.25
Working Capital Turnover Ratio
22.13 52.80 22.13 5.14 5.19
Cash Conversion Cycle
260.99 286.63 260.99 257.84 284.30
Days of Sales Outstanding
61.78 59.72 61.78 74.08 92.76
Days of Inventory Outstanding
289.42 308.49 289.42 281.35 276.74
Days of Payables Outstanding
90.20 81.58 90.20 97.59 85.20
Operating Cycle
351.20 368.21 351.20 355.43 369.51
Cash Flow Ratios
Operating Cash Flow Per Share
629.69 457.89 629.69 718.33 647.20
Free Cash Flow Per Share
221.33 150.61 221.33 599.34 495.81
CapEx Per Share
408.36 307.28 408.36 118.99 151.39
Free Cash Flow to Operating Cash Flow
0.35 0.33 0.35 0.83 0.77
Dividend Paid and CapEx Coverage Ratio
1.07 0.93 1.07 2.39 1.94
Capital Expenditure Coverage Ratio
1.54 1.49 1.54 6.04 4.28
Operating Cash Flow Coverage Ratio
0.22 0.15 0.22 0.26 0.22
Operating Cash Flow to Sales Ratio
0.24 0.17 0.24 0.31 0.32
Free Cash Flow Yield
5.09%3.62%5.09%17.13%12.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.29 45.16 21.29 23.77 16.55
Price-to-Sales (P/S) Ratio
1.68 1.53 1.68 1.53 1.95
Price-to-Book (P/B) Ratio
1.06 0.89 1.06 0.96 1.20
Price-to-Free Cash Flow (P/FCF) Ratio
19.65 27.62 19.65 5.84 8.04
Price-to-Operating Cash Flow Ratio
6.91 9.08 6.91 4.87 6.16
Price-to-Earnings Growth (PEG) Ratio
0.55 -0.82 0.55 -0.61 0.02
Price-to-Fair Value
1.06 0.89 1.06 0.96 1.20
Enterprise Value Multiple
8.95 12.45 8.95 7.58 10.06
Enterprise Value
10.60T 10.89T 10.60T 8.96T 9.89T
EV to EBITDA
8.95 12.45 8.95 7.58 10.06
EV to Sales
2.63 2.55 2.63 2.51 3.09
EV to Free Cash Flow
30.86 46.23 30.86 9.57 12.77
EV to Operating Cash Flow
10.85 15.21 10.85 7.98 9.79
Tangible Book Value Per Share
-1.74K -1.54K -1.74K -1.63K -1.77K
Shareholders’ Equity Per Share
4.09K 4.65K 4.09K 3.63K 3.31K
Tax and Other Ratios
Effective Tax Rate
0.15 -1.73 0.15 0.24 -0.03
Revenue Per Share
2.60K 2.73K 2.60K 2.28K 2.05K
Net Income Per Share
204.29 92.09 204.29 147.14 240.72
Tax Burden
0.85 2.73 0.85 0.76 1.03
Interest Burden
0.76 0.31 0.76 0.71 0.74
Research & Development to Revenue
0.16 0.17 0.16 0.15 0.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.01
Income Quality
3.08 4.97 3.08 4.88 2.69
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis